Genetic testing company 23andMe’s bankruptcy filing in March looked like a glum end to a short, troubled life. The stock had crashed from a peak of $320 in 2021 to less than $2 in March. Losses were mounting, and cash was running out fast.
基因检测公司23andMe公司于今年3月申请破产，这似乎为其短暂而多舛的历程画上了黯淡的句号。该公司股价自2021年高点的320美元暴跌至今年3月的不足2美元。亏损不断扩大，现金也迅速枯竭。
您已阅读8%（334字），剩余92%（3614字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。